These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36709094)

  • 1. The genome editing revolution.
    van der Oost J; Patinios C
    Trends Biotechnol; 2023 Mar; 41(3):396-409. PubMed ID: 36709094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing: intellectual property and product development in plant biotechnology.
    Schinkel H; Schillberg S
    Plant Cell Rep; 2016 Jul; 35(7):1487-91. PubMed ID: 27146974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR as a driving force: the Model T of biotechnology.
    Mariscal C; Petropanagos A
    Monash Bioeth Rev; 2016 Jun; 34(2):101-116. PubMed ID: 27619650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ssDNA recombineering and CRISPR-Cas9 for Pseudomonas putida KT2440 genome editing.
    Wu Z; Chen Z; Gao X; Li J; Shang G
    Appl Microbiol Biotechnol; 2019 Mar; 103(6):2783-2795. PubMed ID: 30762073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
    Bae T; Hur JW; Kim D; Hur JK
    Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas Genome Editing in Filamentous Fungi.
    Rozhkova AM; Kislitsin VY
    Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S120-S139. PubMed ID: 33827404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex genome editing of microorganisms using CRISPR-Cas.
    Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
    FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing.
    Liu R; Liang L; Freed EF; Gill RT
    Trends Biotechnol; 2021 Mar; 39(3):262-273. PubMed ID: 32828556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy biotechnology in the CRISPR-Cas9 era.
    Estrela R; Cate JH
    Curr Opin Biotechnol; 2016 Apr; 38():79-84. PubMed ID: 26874259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR Revolution: Unraveling the mysteries of Life's genetic code.
    Harsij Z; Ghafoorzadeh Z; Goharian E
    Gene; 2024 Jan; 892():147870. PubMed ID: 37797781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape.
    Zhou W; Yuan Y; Zhang Y; Chen D
    CRISPR J; 2021 Jun; 4(3):313-320. PubMed ID: 34152220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genome editing revolution: A CRISPR-Cas TALE off-target story.
    Stella S; Montoya G
    Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas-mediated gene editing in lactic acid bacteria.
    Song X; Zhang XY; Xiong ZQ; Liu XX; Xia YJ; Wang SJ; Ai LZ
    Mol Biol Rep; 2020 Oct; 47(10):8133-8144. PubMed ID: 32926267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer.
    Meng H; Nan M; Li Y; Ding Y; Yin Y; Zhang M
    Front Endocrinol (Lausanne); 2023; 14():1148412. PubMed ID: 37020597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology.
    Javaid D; Ganie SY; Hajam YA; Reshi MS
    Mol Biol Rep; 2022 Dec; 49(12):12133-12150. PubMed ID: 36030476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.